|
Jun 6
|
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
|
|
Jun 6
|
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
|
|
Jun 5
|
Here's Why You Should Add PacBio Stock to Your Portfolio Now
|
|
Jun 4
|
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
|
|
Jun 4
|
What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?
|
|
May 28
|
NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
|
|
May 28
|
Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
|
|
May 26
|
BioSig Stock Surges Following Share Exchange Deal With Streamex
|
|
May 23
|
Reasons to Retain TransMedics Stock in Your Portfolio for Now
|
|
May 22
|
AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech
|
|
May 14
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
|
|
Mar 14
|
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
|
|
Mar 10
|
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
|
|
Feb 24
|
Several Insiders Invested In AngioDynamics Flagging Positive News
|
|
Jan 30
|
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
|
|
Jan 25
|
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
|
|
Jan 8
|
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jan 8
|
AngioDynamics: Fiscal Q2 Earnings Snapshot
|
|
Jan 8
|
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
|
|
Jan 6
|
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
|